While the results with TNF-armed MYXV ex vivo-loaded BM leukocytes as carrier cells showed significant activity in reducing tumor burden and increasing overall survival time in mice compared to animals left untreated or treated with unarmed MYXV, autologous BM transplants are rarely used in the clinic for solid tumors. Here, TNF is linked to neoplasm.